Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer

Background: Immune checkpoint inhibitors (ICIs) have shown efficacy in patients with metastatic urothelial cancer (mUC), however, only a small subset of patients could benefit from ICIs. Identifying predictive biomarkers of ICIs in patients with mUC is clinical meaningful for patient stratification...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Zheng, He, Yuming, Mi, Xiao, Li, Chengcheng, Sun, Xiaoran, Wang, Guoqiang, Li, Leo, Han, Yusheng, Xu, Chunwei, Wang, Wenxian, Cai, Shangli, Wang, Liang, Liu, Zhongyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564431/
https://www.ncbi.nlm.nih.gov/pubmed/37747262
http://dx.doi.org/10.18632/aging.205022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564431/
https://www.ncbi.nlm.nih.gov/pubmed/37747262
http://dx.doi.org/10.18632/aging.205022

Ejemplares similares